| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 2,950 SHS BIOMARIN PHARMACEUTICAL, INC. | 246,018 | 229,864 |
| 6,950 SHS CENTENE CORP. | 410,065 | 429,093 |
| 5,830 SHS CONSOLIDATED EDISON, INC. | 409,400 | 451,300 |
| 5,080 SHS HOLOGIC, INC. | 378,227 | 332,994 |
| 3,000 SHS INCYTE CORP. | 245,769 | 256,140 |
| 16,740 SHS INTERCEPT PHARMACEUTICALS | 379,025 | 331,117 |
| 35,000 SHS MACERICH CO. | 386,718 | 482,650 |
| 3,265 SHS MERCK & CO., INC. | 246,663 | 243,243 |
| 3,080 SHS MODERNA, INC. | 377,969 | 550,766 |
| 12,250 SHS PHILLIPS 66 PARTNERS LP | 378,616 | 423,237 |
| 18,060 SHS PILGRIMS PRIDE CORP. | 409,870 | 432,718 |
| 3,060 SHS QUIDEL CORP. | 376,342 | 320,657 |
| 1,335 SHS RINGCENTRAL, INC. | 378,082 | 425,798 |
| 35,000 SERVICE PROPERTIES TRUST | 416,100 | 431,025 |
| 2,830 SHS SPLUNK, INC. | 379,805 | 357,769 |
| 1,160 SHS VERTEX PHARMACEUTICALS, INC. | 246,410 | 253,112 |
| 8,240 SHS VIACOMBS, INC. | 377,740 | 338,005 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BLAIR & POTTS | 5,750 | 4,312 | 1,438 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK FEES | 272 | 204 | 68 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| 2019 TAX REFUND | 0 | ||
| REFUND | 17,471 | 17,471 | 17,471 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 2020 ESTIMATE | 5,148 | 0 | 0 | |
| FOREIGN TAX WITHHELD | 2,093 | 0 | 0 |